VivoSeq
Explore
Companies
Drugs
Sign In
Report Error
Methadone PCA
Preclinical
Small molecule
F
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
1
Indications
1
Total Trials
0
Active Trials
0
Competitors
Pipeline
Status by Indication
[3]
[1]
Indication
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Opioid-Induced Hyperalgesia
Completed
Preclinical
Phase 1
Phase 2
Phase 3
Approved
Opioid-Induced Hyperalgesia
Preclinical
Completed
Clinical
Trials by Indication
[1]
Opioid-induced Hyperalgesia
1 trial
Perioperative Opioid-induced Hyperalgesia and Its Prevention With Ketamine and Methadone
Completed
·
F
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
·
N/A
·
NCT01594047
·
113 enrolled
Sources
References
[1]
ClinicalTrials.gov
—
1 trial record for Methadone PCA. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL
—
Methadone PCA compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform
—
Drug–disease associations for Methadone PCA. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR
—
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano company filings. U.S. Securities and Exchange Commission.
Details
Drug Info
Quick Facts
Modality
Small molecule
[2]
Highest Phase
Preclinical
[1]
Company
F
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Related News